Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Dr. Majhail on the Importance of Utilizing Social Media in Oncology

March 17th 2021

Navneet Majhail, MD, MS, discusses the importance of utilizing social media in oncology.

A More Simplified Health Care System is Needed to Provide Value

March 1st 2021

Although scientific advances in hematology and oncology have been extraordinary, the US health care system faces significant challenges in ensuring that patients receive high-quality, cost-effective care.

Remembering Henrietta Lacks: Progressing Clinical Cancer Research and Repairing Trust in the Medical Community

February 27th 2021

Although the research that emerged from the discovery of the HeLa cell line has helped to prevent 4.5 billion global infections and 10.3 million global deaths, the unethical and controversial nature of their discovery has raised issues with regard to privacy and consent in underrepresented patient populations.

Practices Grapple With an Aging Oncology Workforce

February 25th 2021

The COVID-19 pandemic may have stalled some physician retirements, but some experts are predicting an exodus of oncologists within the next 1 or 2 years. Practice managers are working now to mitigate the impact with both formal and informal initiatives.

Dr. Markman on Privacy and Consent in Clinical Cancer Trials and Beyond

February 24th 2021

Maurie Markman, MD, discusses how privacy and consent in clinical cancer trials have improved over the years.

Schilsky and Gralow Share Advice for ASCO Leadership and Therapeutic Equity in Cancer

February 15th 2021

Dr. Schilsky highlights key milestones in his career with ASCO, Dr. Gralow speaks to the short- and long-term goals she plans to accomplish in her new role at ASCO, and both speak to their thoughts on the future of cancer care.

Cancer Staging and Toxicity Framework Should Be Overhauled for the Modern Era

February 8th 2021

Formerly, small cell lung cancer was generally considered more chemotherapy sensitive in the short term but also associated with an overall inferior survival outcome; however, the difference in prognosis compared with metastatic non–small cell lung cancer was measured in months—rarely longer.

New Coalition Launches Bid for Cancer Patients Bill of Rights and Multiyear Cancer Care Is Different Platform

February 5th 2021

Introduced today in the state Senate, legislation details six rights for every cancer patient in California.

Harnessing the Potential of Cell and Gene Therapy

February 4th 2021

Although safety remains a concern with gene therapy, investigators are breaking ground in cell and gene therapy, and many believe that ultimately, a string of cured cancers will follow.

Schilsky Says Farewell as Retirement From ASCO Approaches

February 1st 2021

Richard L. Schilsky, MD, FACP, FSCT, FASCO, sat down to share his proudest moments and obstacles throughout his career with ASCO, as well as advice for his successor, Julie Gralow, MD, who will step into the position on February 15, 2021.

Oncology Influencers Explain Do’s and Don’t’s of Social Media

January 12th 2021

Oncologists discuss the use of social media in oncology.

Student Loan Debt, Immigration Status Often Drive Career Decisions for Fellows

December 26th 2020

Investigators from Indiana University decided to study some of the factors influencing career plans for physicians, focusing on current fellows and recent graduates of the hematology and medical oncology specialty in the United States.

Creating the In-Person Experience on a Virtual Platform

December 25th 2020

The coronavirus disease 2019 crisis has changed all aspects of medical education but perhaps altered clinical education most dramatically.

Inaugural AACR Cancer Disparities Progress Report Spotlights Growing Concerns Around Racial Disparities

December 24th 2020

The American Association for Cancer Research revealed a comprehensive, first-of-its-kind AACR Cancer Disparities Progress Report, which highlights disparities in cancer incidence, diagnosis, treatment, and survival, along with a heavy emphasis on racial and ethnic disparities in cancer care.

Fellowship Is a Time for Growth

December 24th 2020

Michael J. Robertson, MD, discusses the value of fellowship, choosing a career path, and the second epiphany that led him to focus on one of the hottest topics in oncology years before it became a viable treatment option.

Dr. Vorobiof on the Impact of Financial Toxicity in the Field of Oncology

December 16th 2020

Daniel A. Vorobiof, MD, the chief medical director of Belong.Life, discusses the impact of financial toxicity on patients with cancer.

Infrastructure of Oncology Care Model Helps Practice Through COVID-19

November 27th 2020

Nothing about taking care of patients with cancer during the coronavirus disease 2019 pandemic has been easy, but those practices that had already embraced transformation under the Oncology Care Model are finding that its monthly payments and other features offer stability during an unprecedented health emergency.

Loaiza-Bonilla on Applications, Actionability, and Affordability of AI in Oncology

November 26th 2020

In our exclusive interview, Dr. Loaiza-Bonilla explains how AI can be used to optimize patient care, provides insight into the research that has been done to develop potential applications for AI in oncology, and sheds light on some of the barriers that have to be overcome in order to effectively implement AI in oncology.

Radiation Oncology Leaders Bristle Over New Medicare Payment Model

November 10th 2020

Practices and cancer centers in randomly selected zip codes will be required to participate in the new radiation oncology Model, which is expected to cover approximately 30% of eligible Medicare fee-for-service care episodes.

Dr. Vorobiof on Financial Toxicity in Oncology

November 3rd 2020

Daniel A. Vorobiof, MD, discusses financial toxicity in oncology.